<th id="3v9ji"></th>
  1. <strong id="3v9ji"></strong>
    <li id="3v9ji"></li><th id="3v9ji"></th>

  2. <button id="3v9ji"><acronym id="3v9ji"><input id="3v9ji"></input></acronym></button>
        1. 聯系電話:512-67626747 聯系郵箱:[email protected]
          翊準國際生物科技/
          動態分子監測 產品系列

          DPYD, TYMS, TYMP, TK1, AND TK2 GENETIC EXPRESSIONS AS RESPON

          發布時間:2016-10-24 ??? 閱讀數:

           DPYD, TYMS, TYMP, TK1, and TK2 Genetic Expressions as Response Markers in Locally Advanced Rectal Cancer Patients Treated with Fluoropyrimidine-Based Chemoradiotherapy

           
          Ming-Yii Huang,1,2,3 Chan-Han Wu,4 Chun-Ming Huang,1,2
          Fu-Yen Chung,4 Ching-Wen Huang,5,6,7 Hsiang-Lin Tsai,3,5,8 Chin-Fan Chen,9
          Shiu-Ru Lin,4 and Jaw-Yuan Wang3,5,6,9,10,11
           
          Received 6 November 2013; Accepted 22 November 2013
           
          Abstract:This study is to investigate multiple chemotherapeutic agent- and radiation-related genetic biomarkers in locally advanced rectal cancer (LARC) patients following fluoropyrimidine-based concurrent chemoradiotherapy (CCRT) for response prediction. We initially selected 6 fluoropyrimidine metabolism-related genes (DPYD, ORPT, TYMS, TYMP, TK1, and TK2) and 3 radiotherapy response-related genes (GLUT1, HIF-1

          上一篇:分子標記抽血檢測 有助腸癌早期診斷
          下一篇:SIGNIFICANT OVEREXPRESSION OF DVL1 IN TAIWANESE COLORECTAL C

          • 蘇州翊準基因科技
            中國江蘇省蘇州市工業園區新平街388號B幢B-203(騰飛創新園塔樓B-203)
            電話:86-512-67626747
            傳真:86-512-67626747

          Copyright © 2016 蘇州翊準基因科技有限公司 版權所有 蘇ICP備17013352號

          日本三级_香港三级_韩国电影三级大全2017_黃色带三级_三级片